English
Polski
Español
українська
Bleeding complications after antithrombotic treatment
What should be the first management steps to be taken immediately upon admission of a patient with bleeding complications of antithrombotic treatment?
2019-01-04
What should be the first management steps to be taken immediately upon admission of a patient with bleeding complications of antithrombotic treatment?
Is there still a place for vitamin K antagonists? When can they be used?
How to correctly assess the risk for thrombosis and risk for bleeding when starting or continuing antithrombotic treatment?
In what patients can we consider reducing the duration of lifelong antithrombotic treatment?
What are some of the new trends in the management of thromboembolism?
What anticoagulation treatment should be used in a patient with active cancer and atrial fibrillation after deep vein thrombosis (DVT)?
In what patients treated with vitamin K antagonists should we use perioperative bridging therapy?
In what patients should antithrombotic treatment be continued despite surgery or invasive procedures?
If no thrombus is seen in the popliteal vein on ultrasonography one month after the event, is it possible it may have travelled to the pulmonary artery?
A 40-year-old otherwise healthy man had a popliteal vein thrombosis after a 9-hour flight. One month after the event there was no sign of a thrombus on ultrasonography and D-dimer levels were normal. What prophylaxis should be used in this patient before long-haul flights in the future?
